Glycomimetics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Glycomimetics Contact Number

Contact Us Glycomimetics

6 hours ago Glycomimetics.com Get All

240.243.1201Contact Us: Our offices are located at 9708 Medical Center DriveRockville, MD 20850. Main phone: +1 240.243.1201 Fax: +1 301.738.2137

Website: http://glycomimetics.com/contact-us/

Category: Contact SupportShow more

GlycoMimetics Overview, News & Competitors …

3 hours ago Zoominfo.com Get All

(240) 243-1201GlycoMimetics’s headquarters are in 9708 Medical Center Dr, Rockville, Maryland, 20850, United States. What is GlycoMimetics’s phone number? GlycoMimetics’s phone number is (240) 243-1201.

Website: https://www.zoominfo.com/c/glycomimetics-inc/33606237

Category: Contact NumberShow more

Home Glycomimetics

6 hours ago Glycomimetics.com Get All

GlycoMimetics to Present at Upcoming H.C. Wainwright & Co Annual Global Investment Virtual Conference. August 9, 2021 GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) August 5, 2021 GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2021

Website: https://glycomimetics.com/

Category: Home PhoneShow more

GlycoMimetics Crunchbase Company Profile & Funding

3 hours ago Crunchbase.com Get All

Contact Email [email protected]glycomimetics.com. Phone Number 2402431207. GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as

Founded: 2003
Founders: John Magnani, Rachel K. King

Website: https://www.crunchbase.com/organization/glycomimetics

Category: Contact NumberShow more

GlycoMimetics Information GlycoMimetics Profile

1 hours ago Rocketreach.co Get All

GlycoMimetics has also completed a Phase 1 clinical trial with another wholly-owned drug candidate, GMI-1359, a combined CXCR4 and E-selectin antagonist. GlycoMimetics is located in Rockville, MD in the BioHealth Capital Region. View Top Employees from GlycoMimetics

Website: https://rocketreach.co/glycomimetics-profile_b5ca9998f42e0bc3

Category: Contact NumberShow more

GLYCOMIMETICS 101 Orchard Dr, Gaithersburg, MD …

3 hours ago Yelp.com Get All

Glycomimetics in Gaithersburg, reviews by real people. Yelp is a fun and easy way to find, recommend and talk about what’s great and not so great in Gaithersburg and beyond.

Location: 101 Orchard Dr Gaithersburg, MD 20878

Website: https://www.yelp.com/biz/glycomimetics-gaithersburg-2

Category: Contact NumberShow more

About Us Glycomimetics

5 hours ago Glycomimetics.com Get All

About Us. GlycoMimetics is a hematology-oncology focused biotechnology company. We are dedicated to improving the lives of patients by discovering, developing and commercializing novel, small-molecule glycomimetic product candidates. Our management team consists of leaders with deep experience in the pharmaceutical/biotech industry.

Website: https://glycomimetics.com/about-us/

Category: Contact NumberShow more

GlycoMimetics Company Profile Management and Employees List

7 hours ago Datanyze.com Get All

(240) 243-1201GlycoMimetics Profile and History . GlycoMimetics is a biotechnology company with a focus in hematology-oncology and a pipeline of novel glycomimetic drugs, all designed to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role.

Employees: 50
Phone: (240) 243-1201
Location: 9708 Medical Center Dr, Rockville, 20850, Maryland

Website: https://www.datanyze.com/companies/glycomimetics/33606237

Category: Contact NumberShow more

John Peterson Vice President, Med.. GlycoMimetics

2 hours ago Zoominfo.com Get All

View John Peterson's business profile as Vice President, Medicinal Chemistry at GlycoMimetics. Find contact's direct phone number, email address, work history, and more.

Website: https://www.zoominfo.com/p/John-Peterson/-2038931587

Category: Contact NumberShow more

MANAGEMENT GlycoMimetics, Inc.

Just Now Ir.glycomimetics.com Get All

Dr. Magnani is co-founder and CSO of GlycoMimetics, Inc (GMI). Prior to co-founding GMI, Dr. Magnani founded and led a predecessor company, GlycoTech Corporation, as its President and CEO. Previously, he helped co-found the U.S. subsidiary of BioCarb and became its international Vice President of Research. Dr.

Website: https://ir.glycomimetics.com/corporate-governance/management

Category: Contact NumberShow more

Uproleselan Glycomimetics

6 hours ago Glycomimetics.com Get All

Uproleselan. GlycoMimetics is developing uproleselan, a specific E-selectin antagonist, to be used in combination with chemotherapy to treat patients with acute myeloid leukemia (AML) and potentially other hematologic cancers. E-selectin plays a critical role in binding cancer cells within vascular niches in the bone marrow, which prevents the

Website: https://glycomimetics.com/pipeline/programs/uproleselan/

Category: Contact NumberShow more

Privacy Policy Glycomimetics

1 hours ago Glycomimetics.com Get All

If you have any questions regarding this Policy and/or our privacy practices, or would like to opt out of future communications, please contact us at: GlycoMimetics, Inc. 9708 Medical Center Drive Rockville, MD …

Website: https://glycomimetics.com/privacy-policy/

Category: Contact NumberShow more

GlycoMimetics Inc. Company Profile The Business Journals

3 hours ago Bizjournals.com Get All

301-417-4224glycomimetics.com. 301-417-4224. 9708 Medical Center Dr., Rockville, MD 20850. Ownership. Public. footnotes. [1] Revenue last updated on Apr 27, 2021 for timeframe: 2020 . [2] Employee count last

Website: https://www.bizjournals.com/profile/company/org_ch_a46938b07b64e104d55183f875a9147d

Category: Contact NumberShow more

Programs Glycomimetics

4 hours ago Glycomimetics.com Get All

GlycoMimetics to Present at Upcoming H.C. Wainwright & Co Annual Global Investment Virtual Conference. August 9, 2021 GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) August 5, 2021 GlycoMimetics Reports Highlights and Financial …

Website: https://glycomimetics.com/pipeline/programs/

Category: Contact NumberShow more

Scientific Publications Glycomimetics

4 hours ago Glycomimetics.com Get All

Discovery Medicine, 2009, Issue 8, Number 43, 247-252. Download Technical Publication- From Carbohydrate Leads to Glycomimetic Drugs B. Ernst and J. L. Magnani Nature Reviews Drug Discovery, 2009, Vol 8, Number 8, 661-677. Download Technical Publication- The Discovery, Biology, and Drug Development of Sialyl Lea and Sialyl Lex J. L. Magnani

Website: https://glycomimetics.com/technology-publications/scientific-publications/

Category: Contact NumberShow more

GLYCOMIMETICS INC Customer Service Center Forecasting

9 hours ago Salary.com Get All

The average salary for Customer Service Center Forecasting/Optimization Manager at companies like GLYCOMIMETICS INC in the United States is $98,890 as of July 28

Website: https://www.salary.com/research/salary/employer/glycomimetics-inc/customer-service-center-forecasting-optimization-manager-salary

Category: Customer ServiceShow more

GlycoMimetics, Inc. (GLYC) Company Profile & Facts Yahoo

4 hours ago Finance.yahoo.com Get All

See the company profile for GlycoMimetics, Inc. (GLYC) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Website: https://finance.yahoo.com/quote/GLYC/profile

Category: Contact NumberShow more

GlycoMimetics LinkedIn

6 hours ago Linkedin.com Get All

GlycoMimetics is a clinical-stage biotechnology company. We use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. Since

Website: https://www.linkedin.com/company/glycomimetics

Category: Contact NumberShow more

GLYC GlycoMimetics Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Get All

GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that clinicians have treated the first patient in a Phase 1b/2 study evaluating the company's lead drug candidate, uproleselan, added to cladribine plus low dose cytarabine (LDAC) in patients with treated secondary AML (ts-AML). The investigator-sponsored trial is being led by Tapan Kadia, M.D

Website: https://www.biopharmcatalyst.com/company/glyc

Category: Contact NumberShow more

GlycoMimetics Doses First Patient in Phase 2 Portion of

9 hours ago Businesswire.com Get All

650-888-0902GlycoMimetics, Inc. Investor Contact: Shari Annes, 650-888-0902 [email protected] or Media Contact: Jamie Lacey-Moreira, 410-299-3310 [email protected] Contacts

Website: https://www.businesswire.com/news/home/20160628005749/en/GlycoMimetics-Doses-Patient-Phase-2-Portion-Clinical

Category: Contact NumberShow more

GlycoMimetics Number of Employees 20122021 GLYC

Just Now Macrotrends.net Get All

GlycoMimetics number of employees from 2012 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a …

Website: https://www.macrotrends.net/stocks/charts/GLYC/glycomimetics/number-of-employees

Category: Contact NumberShow more

Premarket Mover: GlycoMimetics Inc (GLYC) Up 7.26%

8 hours ago Investorsobserver.com Get All

In the Biotechnology industry which is number 130 by this metric, GLYC ranks better than 38% of stocks. Important Dates for Investors in GLYC:-GlycoMimetics Inc is set to release earnings on 11/5/2021. During their last earnings release the company posted EPS of $-1.18. -We do not have a set dividend date for GlycoMimetics Inc at this time.

Website: https://www.investorsobserver.com/news/stock-update/premarket-mover-glycomimetics-inc-glyc-up-7-26

Category: Contact NumberShow more

GlycoMimetics Company Profile Office Locations

Just Now Craft.co Get All

GlycoMimetics has 50 employees at their 1 location and $10.16 M in annual revenue in FY 2020. See insights on GlycoMimetics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Website: https://craft.co/glycomimetics

Category: Contact NumberShow more

GlycoMimetics to Receive European Patent for GMI1271

2 hours ago Businesswire.com Get All

650-888-0902GlycoMimetics, Inc. Investor Contact: Shari Annes, 650-888-0902 [email protected] or Media Contact: Jamie Lacey-Moreira, 410-299-3310 [email protected] Contacts

Website: http://www.businesswire.com/news/home/20170706005056/en/GlycoMimetics-Receive-European-Patent-GMI-1271

Category: Contact NumberShow more

GlycoMimetics to Report Second Quarter Financial Results

6 hours ago Ir.glycomimetics.com Get All

(844) 413-7154ROCKVILLE, Md.--(BUSINESS WIRE)--Jul. 29, 2021-- GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that it will host a conference call and webcast to report its second quarter financial results on Thursday, August 5, 2021, at 8:30 a.m. ET. The dial-in number for the conference call is (844) 413-7154 for domestic participants and (216) 562-0466 for international participants, with participant

Website: https://ir.glycomimetics.com/news-releases/news-release-details/glycomimetics-report-second-quarter-financial-results-august-5

Category: Contact NumberShow more

GlycoMimetics, Inc. (GLYC) Stock Price Today, Quote & News

6 hours ago Seekingalpha.com Get All

A high-level overview of GlycoMimetics, Inc. (GLYC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Website: https://seekingalpha.com/symbol/GLYC

Category: Contact NumberShow more

GlycoMimetics, Inc. (GLYC) Stock Price, News, Quote

6 hours ago Finance.yahoo.com Get All

ROCKVILLE, Md., August 05, 2021--GlycoMimetics, Inc. (Nasdaq: GLYC) today reported its financial results for the quarter ended June 30, 2021 and highlighted recent events. Cash and cash

Website: https://finance.yahoo.com/quote/GLYC

Category: Contact NumberShow more

GlycoMimetics to Receive European Patent for GMI1271

3 hours ago Businesswire.com Get All

650-888-0902GlycoMimetics, Inc. Investor Contact: Shari Annes, 650-888-0902 [email protected] or Media Contact: Jamie Lacey-Moreira, 410-299-3310 [email protected] Contacts

Website: https://www.businesswire.com/news/home/20170706005056/en/GlycoMimetics-Receive-European-Patent-GMI-1271

Category: Contact NumberShow more

GlycoMimetics Inc. (GLYC) Shows Downtrend But Still 29.78%

Just Now Baxterreport.com Get All

The total number of common shares currently owned by the public is 51.54 million. GLYC does have institutional investors; and they hold 65.60% of the stock. GlycoMimetics Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 0 new insider purchases involving 0 shares.

Website: https://baxterreport.com/2021/09/09/glycomimetics-inc-glyc-shows-downtrend-but-still-29-78-up-from-recent-low/

Category: Contact NumberShow more

GlycoMimetics, Inc. (GLYC) Balance Sheet Yahoo Finance

1 hours ago Finance.yahoo.com Get All

Get the annual and quarterly balance sheet of GlycoMimetics, Inc. (GLYC) including details of assets, liabilities and shareholders' equity.

Website: https://finance.yahoo.com/quote/GLYC/balance-sheet/

Category: Contact NumberShow more

GlycoMimetics and Apollomics Announce Exclusive

2 hours ago Businesswire.com Get All

650-888-0902GlycoMimetics Contacts Investor Contact: Shari Annes Phone: 650-888-0902 Email: [email protected] Media Contact: Jamie Lacey-Moreira Phone: 410-299-3310 Email: [email protected]

Website: https://www.businesswire.com/news/home/20200106005583/en/GlycoMimetics-Apollomics-Announce-Exclusive-Collaboration-License-Agreement

Category: Contact NumberShow more

GlycoMimetics, Inc. (GLYC) Stock Major Holders Yahoo Finance

4 hours ago Finance.yahoo.com Get All

Find out the direct holders, institutional holders and mutual fund holders for GlycoMimetics, Inc. (GLYC).

Website: https://finance.yahoo.com/quote/GLYC/holders

Category: Contact NumberShow more

GLYCOMIMETICS INC Technical Customer Service

4 hours ago Salary.com Get All

The average salary for Technical Customer Service Representative at companies like GLYCOMIMETICS INC in the United States is $68,100 as of July 28, 2021, but the range typically falls between $57,800 and $81,900. Salary ranges can vary widely depending on many important factors, including education, certifications, additional skills, the number

Website: https://www.salary.com/research/salary/employer/glycomimetics-inc/technical-customer-service-representative-salary

Category: Customer Service, Technical Support, Tech SupportShow more

GlycoMimetics to Report Third Quarter 2018 Financial

7 hours ago Businesswire.com Get All

650-888-0902GlycoMimetics, Inc. Investor Contact: Shari Annes, 650-888-0902 [email protected] or Media Contact: Jamie Lacey-Moreira, 410-299-3310 [email protected] Contacts

Website: https://www.businesswire.com/news/home/20181026005014/en/GlycoMimetics-Report-Quarter-2018-Financial-Results-November

Category: Contact NumberShow more

What Kind Of Investors Own Most Of GlycoMimetics, Inc

Just Now Nasdaq.com Get All

021-09-10GlycoMimetics is a smaller company with a market capitalization of US$104m, so it may still be flying under the radar of many institutional investors. There are a reasonable number of analysts

Website: https://www.nasdaq.com/articles/what-kind-of-investors-own-most-of-glycomimetics-inc.-nasdaq%3Aglyc-2021-09-10

Category: Contact NumberShow more

GlycoMimetics to Present at AACR 2021 Meeting on Positive

3 hours ago Businesswire.com Get All

650-888-0902Investor Contact: Shari Annes Phone: 650-888-0902 Email: [email protected] Media Contact: Jamie Lacey-Moreira Phone: 410-299-3310 Email: [email protected] Contacts

Website: https://www.businesswire.com/news/home/20210410005014/en/GlycoMimetics-to-Present-at-AACR-2021-Meeting-on-Positive-Therapeutic-Effects-of-GMI-1757-in-a-Pancreatic-Adenocarcinoma-Model

Category: Contact NumberShow more

Are Institutions Heavily Invested In GlycoMimetics, Inc.'s

3 hours ago Finance.yahoo.com Get All

The big shareholder groups in GlycoMimetics, Inc. (NASDAQ:GLYC) have power over the company. Institutions often own shares in more established companies, while it's not unusual to …

Website: https://finance.yahoo.com/news/institutions-heavily-invested-glycomimetics-inc-121024476.html

Category: Contact NumberShow more

GlycoMimetics to Report First Quarter 2018 Financial

Just Now Businesswire.com Get All

650-888-0902GlycoMimetics, Inc. Investor Contact: Shari Annes, 650-888-0902 [email protected] or Media Contact: Jamie Lacey-Moreira, 410-299-3310 [email protected] Contacts

Website: https://www.businesswire.com/news/home/20180426005813/en/GlycoMimetics-Report-Quarter-2018-Financial-Results-3

Category: Contact NumberShow more

GlycoMimetics Inc (GLYC) Stock: What Does the Chart Say

4 hours ago Investorsobserver.com Get All

GlycoMimetics Inc (GLYC) stock has gained 4% while the S&P 500 has fallen -0.06% as of 10:16 AM on Wednesday, Sep 8. GLYC has risen $0.09 from the previous closing price of $2.25 on volume of 215,720 shares. Over the past year the S&P 500 has risen 35.58% while GLYC has fallen -31.58%. GLYC lost -$1.17 per share in the over the last 12 months.

Website: https://www.investorsobserver.com/news/stock-update/glycomimetics-inc-glyc-stock-what-does-the-chart-say-wednesday

Category: Contact NumberShow more

Is Glycomimetics Stock a good investment? GLYC Macroaxis

Just Now Macroaxis.com Get All

Glycomimetics is trading at 2.25 as of the 13th of September 2021, a -1.32 percent decrease since the beginning of the trading day. The stock's open price was 2.28. Get the latest Glycomimetics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Glycomimetics Stock investment advice, charts, stats and more.

Website: https://www.macroaxis.com/stock/GLYC/GlycoMimetics

Category: Contact NumberShow more

GlycoMimetics, inc (GLYC) Q2 2021 Earnings Call Transcript

9 hours ago Fool.com Get All

Thank you, Rachel. As of June 30, 2021, GlycoMimetics had cash and cash equivalents of $118.9 million as compared to $137 million as of December 31, 2020. Research and development expenses

Website: https://www.fool.com/earnings/call-transcripts/2021/08/07/glycomimetics-inc-glyc-q2-2021-earnings-call-trans/

Category: Contact NumberShow more

GlycoMimetics (GLYC) Company Profile & Overview Stock

6 hours ago Stockanalysis.com Get All

GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company's drug candidate include rivipansel, a pan-selectin antagonist for the treatment of vaso-occlusive crisis in sickle cell disease.

Website: https://stockanalysis.com/stocks/glyc/company/

Category: Contact NumberShow more

GlycoMimetics Inc. (NASDAQ:GLYC) Stock Ripped 40.16% Year

4 hours ago Marketingsentinel.com Get All

GlycoMimetics Inc.’s shares saw a change of -40.16% in year-to-date performance and have moved -0.88% in past 5-day. GlycoMimetics Inc. (NASDAQ:GLYC) showed a performance of 11.39% in past 30-days. Number of shares sold short was 1.54 million shares which …

Website: https://marketingsentinel.com/2021/09/11/glycomimetics-inc-nasdaqglyc-stock-ripped-40-16-year-to-date-what-will-happen-next/

Category: Contact NumberShow more

GlycoMimetics, Inc. (GLYC) Interactive Stock Chart Yahoo

3 hours ago Finance.yahoo.com Get All

GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2021. ROCKVILLE, Md., August 05, 2021--GlycoMimetics, Inc. (Nasdaq: GLYC) today reported its financial results for the

Website: https://finance.yahoo.com/quote/GLYC/chart/

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Who is the CEO of glycomimetics, Inc?

GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that Chief Executive Officer Rachel King will provide a company overview at the Jefferies 2021 Virtual Healthcare Conference. Ms. King’s presentation will take place from 2:30 to 2:55 p.m. on June 3, 2021. More information is available in the Investors section of the GlycoMimetics website.

What are the drug candidates of glycomimetics Inc?

The company’s drug candidate include rivipansel, a pan-selectin antagonist for the treatment of vaso-occlusive crisis in sickle cell disease. It is also developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as Phase 3 trial to treat relapsed/refractory AML.

Is it a good time to buy GLYC stock?

Investors need to pay close attention to GlycoMimetics (GLYC) stock based on the movements in the options market lately. Market volatility is up in recent sessions, and while that may have applied a brake to the upward trend, it also opens up opportunities for investors willing to shoulder some extra risk.

Who is the principal investigator of glycomimetics clinical trial?

Keith Stockerl-Goldstein, M.D., Professor of Medicine, Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine, is the clinical trial’s principal investigator. Investors need to pay close attention to GlycoMimetics (GLYC) stock based on the movements in the options market lately.

Popular Brands

Godrej
Gbl
Gic
Gati
Geely
Gpa
Gevo
Geron